What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE.
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from Amwill Health Care Limited's filed financials and exchange disclosures
Amwill Health Care Limited is a Pharmaceuticals & Biotechnology company listed on BSE.
Effectively yes. It holds ₹16 Cr more cash than debt.
On trailing P/E, Amwill Health Care Limited ranks 16 of 169 in Pharmaceuticals — cheaper than 91% of them, against an industry median of 28.9×. This is a position, not a valuation judgement.
On a typical session Amwill Health Care Limited moves 1.98% — that is the median absolute close-to-close move across its last 248 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by Amwill Health Care Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
